Innovation-Driven Pharmacovigilance (PV)

Technology advances and the impact on regulators and industry

Pharmacovigilance (PV) challenges are growing for both regulators and industry. Adverse Event (AE) case volumes and sources are growing rapidly, while personalized medicine increases complexity. Manual processes and legacy technology are creating barriers to efficiency and innovation. To successfully manage the balance of benefit vs. risk in PV, companies, and agencies will need to adopt technologies like agile PV platforms, natural language processing (NLP), and artificial intelligence (AI).

In this whitepaper, learn how the right combination of out-of-the-box Pharmacovigilance (PV) features and technology platform capabilities can help both industry and regulators “future-proof” their PV operations.

Learn more about Pega Pharmacovigilance.


Related Resources

PegaWorld 2018 promo card

PegaWorld 2018

Registration is Now Open

Discover why 4,500 global leaders plan to join us next June in Las Vegas!

The Salesforce.com Alternative

Considering Salesforce.com?

Don’t fall for the hype. See why today’s leading enterprises choose Pega CRM.